ADAMTS9 and breast carcinoma: Here, inhibiting the expression of TGFBR2 could weaken the tumor suppressor effect of ADAMTS9-AS1, suggesting that TGFBR2 was an inhibitor in breast cancer, which is similar to the results of previous studies.